Cargando…
The radioprotectant nano-genistein enhances radiotherapy efficacy of lung tumors in mice
BACKGROUND: Radiotherapy for non-small cell lung cancer (NSCLC) can be dose-limiting due to treatment-related toxicities. Genistein has been shown to be a robust radioprotective agent in preclinical models. A novel genistein oral nanosuspension formulation (nano-genistein) has demonstrated efficacy...
Autores principales: | Kaytor, Michael D., Serebrenik, Artur A., Lapanowski, Karen, McFall, Debra, Jones, Matthew, Movsas, Benjamin, Simone, Charles B., Brown, Stephen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261856/ https://www.ncbi.nlm.nih.gov/pubmed/37323169 http://dx.doi.org/10.21037/tlcr-22-856 |
Ejemplares similares
-
Radioprotection et radiothérapie
Publicado: (1975) -
Pharmacokinetic and metabolomic studies with a BIO 300 Oral Powder formulation in nonhuman primates
por: Li, Yaoxiang, et al.
Publicado: (2022) -
Pharmacokinetic and Metabolomic Studies with BIO 300, a Nanosuspension of Genistein, in a Nonhuman Primate Model
por: Cheema, Amrita K., et al.
Publicado: (2019) -
La radioprotection
por: Bonet-Maury, P
Publicado: (1969) -
Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents
por: Callaghan, Cameron M., et al.
Publicado: (2020)